Download Files:
Products Details
Product Description
– BQZ-485 is a a potent GDI2 inhibitor through the interaction with Tyr245. BQZ-485 disrupts the intrinsic GDI2-Rab1A interaction, thereby abolishing vesicular transport from the endoplasmic reticulum (ER) to the Golgi apparatus and initiating subsequent paraptosis events[1].
Web ID
– HY-156242
Shipping
– Room temperature
Molecular Formula
– C32H39NO3
References
– [1]Yong Sun, et al. Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[a]quinolizidine Library to Induce Paraptosis for Cancer Therapy. JACS Au 2023, September 26, 2023.
CAS Number
– 1906915-49-8
Molecular Weight
– 485.66
SMILES
– CC1=CC(C)=CC(COC2=CC3=C([C@](C[C@@H](O)C[C@@H]4C)([H])N4CC3)C=C2OCC5=CC(C)=CC(C)=C5)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Apoptosis
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
